Ipca Laboratories Limited logo

Ipca Laboratories Limited

NSE:IPCALAB.NS

Overview | Financials
Company Name Ipca Laboratories Limited
Symbol IPCALAB.NS
Currency INR
Price 1,454.35
Market Cap 368,974,412,400
Dividend Yield 0.16%
52-week-range 878 - 1,479.9
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Pranay Premchand Godha
Website https://www.ipca.com

An error occurred while fetching data.

About Ipca Laboratories Limited

Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive,

Related Stocks

GlaxoSmithKline Pharmaceuticals Limited logo

GlaxoSmithKline Pharmaceuticals Limited

GLAXO.NS

2,698.35 INR

Syngene International Limited logo

Syngene International Limited

SYNGENE.NS

902.1 INR

Lupin Limited logo

Lupin Limited

LUPIN.NS

2,171.9 INR

Pfizer Limited logo

Pfizer Limited

PFIZER.NS

5,667.3 INR

Fortis Healthcare Limited logo

Fortis Healthcare Limited

FORTIS.NS

590.5 INR

Laurus Labs Limited logo

Laurus Labs Limited

LAURUSLABS.NS

470.4 INR

Aurobindo Pharma Limited logo

Aurobindo Pharma Limited

AUROPHARMA.NS

1,528.1 INR

Dr. Lal PathLabs Limited logo

Dr. Lal PathLabs Limited

LALPATHLAB.NS

3,274.8 INR

Sanofi India Limited logo

Sanofi India Limited

SANOFI.NS

7,177.55 INR

Ajanta Pharma Limited logo

Ajanta Pharma Limited

AJANTPHARM.NS

3,198.5 INR

Financials

Numbers are in millions USD

Numbers are in millions USD